Section Arrow
VVOS.NASDAQ
- Vivos Therapeutics
Quotes are at least 15-min delayed:2026/03/13 04:52 EDT
Pre Market
Last
 --
-- (--)
Bid
1.27
Ask
1.4
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 1.3
-0.04 (-2.99%)
Day High 
1.4 
Prev. Close
1.34 
1-M High
1.7245 
Volume 
80.87K 
Bid
1.27
Ask
1.4
Day Low
1.29 
Open
1.37 
1-M Low
1.26 
Market Cap 
14.03M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.38 
20-SMA 1.48 
50-SMA 1.74 
52-W High 7.95 
52-W Low 1.26 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.77/-1.02
Enterprise Value
15.06M
Balance Sheet
Book Value Per Share
0.24
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
15.03M
Operating Revenue Per Share
1.48
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp68.55-1.08-1.55%35.77PE
Pre Market 68.5 -0.05 -0.07%
MDTMedtronic plc87.38-1.59-1.79%24.87PE
Pre Market 87.57 +0.19 +0.22%
ABTAbbott Laboratories108.14-2.11-1.91%29.57PE
Pre Market -- -- --
PACBPacific Biosciences of California1.27-0.08-5.93%-- 
Pre Market 1.28 +0.01 +0.79%
DXCMDexCom65.26-1.05-1.58%31.96PE
Pre Market 65.25 -0.01 -0.02%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.